TY - JOUR
T1 - A population-based study of neurologic manifestations of severe influenza A(H1N1)pdm09 in california
AU - Glaser, Carol A.
AU - Winter, Kathleen
AU - DuBray, Kara
AU - Harriman, Kathleen
AU - Uyeki, Timothy M.
AU - Sejvar, James
AU - Gilliam, Sabrina
AU - Louie, Janice K.
PY - 2012/8/15
Y1 - 2012/8/15
N2 - Background. Reported influenza-associated neurologic complications are generally limited to case series or case reports. We conducted a population-based study of neurologic manifestations associated with severe and fatal influenza A(H1N1)pdm09 (2009 H1N1) cases. Methods. Medical records of patients with fatal or severe (hospitalized in intensive care unit) laboratoryconfirmed 2009 H1N1 reported to the California Department of Public Health from 15 April 2009 through 31 December 2009 were reviewed to identify those with primary neurological manifestations. Cases with secondary neurologic manifestations (eg, hypoxia) were excluded. Primary influenza-associated neurologic complications (INCs) were classified into 4 groups: encephalopathy/encephalitis, seizures, meningitis, and other. Severe 2009 H1N1-associated neurologic incidence was calculated by using estimates of 2009 H1N1 illnesses in California. Results. Of 2069 reported severe or fatal 2009 H1N1 cases, 419 (20%) had neurologic manifestations. Of these, 77 (18%) met our definition of INCs: encephalopathy/encephalitis (n = 29), seizures (n = 44), meningitis (n = 3), and other (Guillain-Barré Syndrome) (n = 1). The median age was 9 years (range, 4 months-92 years); the highest rate of disease was among pediatric Asian/Pacific Islanders (12.79 per 1 000 000) compared with pediatric white, non-Hispanics (3.09 per 1 000 000), Hispanics (4.58 per 1 000 000), and blacks (6.57 per 1 000 000). The median length of stay (LOS) was 4 days (range, 1-142), and there were 4 fatalities. The estimated incidence of INCs was 1.2 per 100 000 symptomatic 2009 H1N1 illnesses. Conclusions. Influenza-associated neurologic complications were observed in 4% of patients with fatal or severe 2009 H1N1. They were observed most often in pediatric patients, and Asian/Pacific Islanders appear to be overrepresented compared with the California population. Most patients with INCs had a relatively short LOS, and there were few fatalities.
AB - Background. Reported influenza-associated neurologic complications are generally limited to case series or case reports. We conducted a population-based study of neurologic manifestations associated with severe and fatal influenza A(H1N1)pdm09 (2009 H1N1) cases. Methods. Medical records of patients with fatal or severe (hospitalized in intensive care unit) laboratoryconfirmed 2009 H1N1 reported to the California Department of Public Health from 15 April 2009 through 31 December 2009 were reviewed to identify those with primary neurological manifestations. Cases with secondary neurologic manifestations (eg, hypoxia) were excluded. Primary influenza-associated neurologic complications (INCs) were classified into 4 groups: encephalopathy/encephalitis, seizures, meningitis, and other. Severe 2009 H1N1-associated neurologic incidence was calculated by using estimates of 2009 H1N1 illnesses in California. Results. Of 2069 reported severe or fatal 2009 H1N1 cases, 419 (20%) had neurologic manifestations. Of these, 77 (18%) met our definition of INCs: encephalopathy/encephalitis (n = 29), seizures (n = 44), meningitis (n = 3), and other (Guillain-Barré Syndrome) (n = 1). The median age was 9 years (range, 4 months-92 years); the highest rate of disease was among pediatric Asian/Pacific Islanders (12.79 per 1 000 000) compared with pediatric white, non-Hispanics (3.09 per 1 000 000), Hispanics (4.58 per 1 000 000), and blacks (6.57 per 1 000 000). The median length of stay (LOS) was 4 days (range, 1-142), and there were 4 fatalities. The estimated incidence of INCs was 1.2 per 100 000 symptomatic 2009 H1N1 illnesses. Conclusions. Influenza-associated neurologic complications were observed in 4% of patients with fatal or severe 2009 H1N1. They were observed most often in pediatric patients, and Asian/Pacific Islanders appear to be overrepresented compared with the California population. Most patients with INCs had a relatively short LOS, and there were few fatalities.
UR - http://www.scopus.com/inward/record.url?scp=84864448608&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864448608&partnerID=8YFLogxK
U2 - 10.1093/cid/cis454
DO - 10.1093/cid/cis454
M3 - Article
C2 - 22573853
AN - SCOPUS:84864448608
SN - 1058-4838
VL - 55
SP - 514
EP - 520
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 4
ER -